¾Ã²Ý¸£Àû

All publications

Journal articles

• Mensah JP, Akparibo R, Thomas C, Aryeetey R & Brennan A (2025) . BMJ Open, 15(10), e100490-e100490.
• Taggart L, McDermott G, Dunkley A, Truesdale M, Coates V, Khunti K, Clarke M, Pollard D, Brennan A, Hadjiconstantinou M , Caba M et al (2025) . NIHR Open Research, 5.
• Squires H, Gillespie D, Kock L, Hock E, Hiscock R, Bogdanovica I, Lewis C, Robson D, Filippidis F, Langley T , Pulsford E et al (2025) . NIHR Open Research.
• Tunstall H, Wilson LB, Valiente R, Shortt NK, Angus C, Brennan A, Gillespie D & Pearce J (2025) . Tobacco Control.
• Pollard DJ, Besser REJ, Dayan C, Townson J, Singh H, Greenwood R, Farmer A, Aveyard P & Brennan A (2025) . NIHR Open Research, 5.
• Buckley C, Breeze P, Keenan G, Brennan A & Purshouse RC (2025) . Appetite, 213, 108071-108071.
• Guess N, Wane S, Albury C, Breeze P, Brennan A, Joyce JB, Galal U, Morris E, Newbert C, Mitchell C , Yu L-M et al (2025) . Contemporary Clinical Trials, 157, 108050-108050.
• West R, Brown J, Shahab L, Baird H, Webb T, Squires H, Tattan-Birch H, Gillespie D, Purshouse R, Brennan A , Mazumdar S et al (2025) . Wellcome Open Research, 10, 455-455.
• Theodoulou E, Martin C, Morgan J, Turner O, Hartup S, Achuthan R, Azmy I, Henderson J, Reed M, Holen I , Brown J et al (2025) . Journal of Geriatric Oncology, 16(7).
• Gharibzadeh S, Lee J, Highton P, Greenlaw N, Gillies C, Zaccardi F, Brennan A, Pollard DJ, Valabhji J, Game F , Stanley B et al (2025) . Diabetes, Obesity and Metabolism.
• Gillespie D, Morris D, Angus C, Wilson LB, Chen RKL, Leeming G, Holmes J & Brennan A (2025) . Tobacco Control.
• Flight L, Brennan A, Chick SE, Forster M, Julious S & Tharmanathan P (2025) . BMC Medical Research Methodology, 25(1).
• Masuku SD, Mandrik O, Mdege ND, Mishra G, Muwonge R, Meyer-Rath G, Lince-Deroche N & Brennan A (2025) . Value in Health Regional Issues, 49.
• Breeze P, Pidd K, Pollard D, Ren S, Bates S, Thomas C, Ahern A, Griffin S & Brennan A (2025) . International Journal of Obesity, 49(8), 1598-1607.
• Pidd K, Breeze P, Ahern A, Griffin SJ & Brennan A (2025) . BMJ Open, 15(4).
• Onuwe T, Highton PJ, Batchelor D, Brennan A, Caba M, Davies MJ, Funnell MP, Game F, Gillies CL, Glab A , Gray LJ et al (2025) . Diabetic Medicine, 42(6).
• Jones RA, Mueller J, Richards R, Woolston J, Stubbings M, Whittle F, Hill AJ, Hughes CA, Duschinsky R, Sharp SJ , Chester M et al (2025) . Obesity Science & Practice, 11(2).
• Davies MJ, Agarwal S, Bodicoat DH, Brennan A, Dixon S, Eborall H, Glab A, Gray LJ, Hadjiconstantinou M, Huddlestone L , Hudson N et al (2025) . Programme Grants for Applied Research, 13(2), 1-72.
• Mueller J, Breeze P, Fusco F, Sharp SJ, Pidd K, Brennan A, Hill AJ, Morris S, Hughes CA, Bates SE , Pollard D et al (2025) . Diabetologia, 68(5), 969-980.
• Wilson LB, Angus C, Brennan A, Gillespie D, Shortt NK, Tunstall H, Valiente R & Pearce J (2025) . Tobacco Control.
• Mensah JP, Thomas C, Akparibo R & Brennan A (2025) . BMC Public Health, 25(1).
• Bates S, Saidi Y, Cookson R, Skarda I, Ford T, Hayes R, Ganguli P, Byford S & Brennan A (2025) . Value in Health, 28(3), 326-335.
• Heath A, Brennan A & Grimm S (2024) . Value in Health, 27(12), S471-S472.
• Saidi Y, Brennan A & Weich S (2024) . The Lancet, 404(Supplement 1), S13-S13.
• Bates S, Saidi Y, Cookson R, Skarda I, Ford T, Hayes R, Ganguli P, Byford S & Brennan A (2024) . European Journal of Public Health, 34(Supplement_3).
• Squires H, Kelly MP, Gilbert N, Sniehotta F, Purshouse RC, Garcia L, Breeze P, Brennan A, Gardner B, Bright S , Fischer A et al (2024) . BMC Public Health, 24(1).
• Morris D, Angus C, Gillespie D, Stevely A, Pryce R, Wilson L, Henney M, Meier P, Holmes J & Brennan A (2024) . The Lancet Public Health, 9(10), e719-e728.
• Opazo Breton M, Henney M, Kersbergen I, Brennan A & Holmes J (2024) . Addiction, 119(10), 1726-1736.
• Flight L, Brennan A, Wilson I & Chick SE (2024) . Value in Health, 27(10), 1328-1337.
• Buckell J, Mitchell CA, Fryer K, Newbert C, Brennan A, Joyce J, Jebb SA, Aveyard P, Guess N & Morris E (2024) . Diabetes Care, 47(7), 1239-1239.
• Davies MJ, Bodicoat DH, Brennan A, Dixon S, Eborall H, Glab A, Gray LJ, Hadjiconstantinou M, Huddlestone L, Hudson N , Keetharuth A et al (2024) . BMC Primary Care, 25.
• Heathcote L, Pollard D, Brennan A, Davies M, Eborall H, Edwardson C, Gillett M, Gray L, Griffin S, Hardeman W , Henson J et al (2024) . BMJ Open Diabetes Research and Care, 12(2).
• Bates S, Breeze P, Thomas C, Jackson C, Church O & Brennan A (2024) . BMC Public Health, 24.
• Höhn A, Lomax N, Rice H, Angus C, Brennan A, Brown D, Cunningham A, Elsenbroich C, Hughes C, Katikireddi SV , McCartney G et al (2024) . BMJ Open, 14(3).
• Buckell J, Mitchell C, Fryer K, Newbert C, Brennan A, Joyce J, Aveyard P, Jebb S, Guess N & Morris E (2024) . Diabetes Care, 47(4), 739-746.
• Valiente R, Tunstall H, Kong AY, Wilson LB, Gillespie D, Angus C, Brennan A, Shortt NK & Pearce J (2024) . Tobacco Control.
• Purshouse RC, Buckley C & Brennan A (2024) . Environmental Modelling & Software, 173.
• Pryce R, Wilson LB, Gillespie D, Angus C, Morris D & Brennan A (2024) . Drug and Alcohol Review, 43(1), 315-324.
• Mensah J, Thomas C, Akparibo R & Brennan A (2023) . Value in Health, 26(12), S544-S544.
• Pidd K, Breeze P, Pollard D, Ahern A, Mueller J & Brennan A (2023) . The Lancet, 402(1), S75-S75.
• Hatchard J, Buykx P, Wilson L, Brennan A & Gillespie D (2023) . International Journal of Drug Policy, 122.
• Hatchard J, Buykx P, Brennan A & Gillespie D (2023) . NIHR Open Research, 3(26).
• Hatchard J, Buykx P, Brennan A & Gillespie D (2023) . NIHR Open Research, 3(26).
• Mueller J, Jones RA, Richards R, Woolston J, Whittle F, Hill AJ, Hughes CA, Duschinsky R, Sharp SJ, Boothby C , Bostock J et al (2023) . Appetite, 189, 106907-106907.
• Søholm U, Zaremba N, Broadley M, Axelsen JL, Divilly P, Martine-Edith G, Amiel SA, Mader JK, Pedersen-Bjergaard U, McCrimmon RJ , Renard E et al (2023) . JMIR Diabetes, 8(1).
• Buckley C, Breeze P, Brennan A, Colasanti R, Leach M & Purshouse R (2023) . Appetite, 189, 106933-106933.
• Stevely AK, Mackay D, Alava MH, Brennan A, Meier PS, Sasso A & Holmes J (2023) . Public Health, 220, 43-49.
• Hatchard J, Buykx P, Brennan A & Gillespie D (2023) . NIHR Open Research, 3.
• Valiente R, Tunstall H, Kong A, Wilson L, Gillespie D, Angus C, Brennan A, Shortt N & Pearce J (2023) . Tobacco Prevention & Cessation, 9(Supplement), 57-57.
• Breeze PR, Squires H, Ennis K, Meier P, Hayes K, Lomax N, Shiell A, Kee F, de Vocht F, O’Flaherty M , Gilbert N et al (2023) . Health Economics, 32(7), 1603-1625.
• Vu TM, Buckley C, Duro JA, Brennan A, Epstein JM & Purshouse RC (2023) . Journal of Artificial Societies and Social Simulation, 26(2).
• Buckley C, Brennan A, Kerr W, Probst C, Puka K, Purshouse R & Rehm J (2022) . International Journal of Alcohol and Drug Research, 10(1), 24-33.
• Brennan A, Angus C, Pryce R, Buykx P, Henney M, Gillespie D, Holmes J & Meier PS (2022) . Addiction.
• Ahern AL, Breeze P, Fusco F, Sharp SJ, Islam N, Wheeler GM, Hill AJ, Hughes CA, Duschinsky R, Thomas C , Bates S et al (2022) . The Lancet Public Health, 7(10), e866-e875.
• Broadley M, Chatwin H, Søholm U, Amiel SA, Carlton J, De Galan BE, Hendrieckx C, McCrimmon RJ, Skovlund SE, Pouwer F & Speight J (2022) . BMJ Open Diabetes Research and Care, 10(4).
• Thomas C, Breeze P, Cummins S, Cornelsen L, Yau A & Brennan A (2022) . International Journal of Behavioral Nutrition and Physical Activity, 19.
• Breeze P, Gray LA, Thomas C, Bates SE & Brennan A (2022) . Quality of Life Research, 31(11), 3283-3292.
• Wyld L, Reed MWR, Collins K, Ward S, Holmes G, Morgan J, Bradburn M, Walters S, Burton M, Lifford K , Edwards A et al (2022) . Programme Grants for Applied Research, 10(6), 1-114.
• Divilly P, Zaremba N, Mahmoudi Z, Søholm U, Pollard D, Broadley M, Abbink E, de Galan B, Pedersen-Bjergaard U, Renard E , Evans M et al (2022) . Diabetic Medicine, 39(9).
• Ahern AL, Richards R, Jones RA, Whittle F, Mueller J, Woolston J, Sharp SJ, Hughes CA, Hill AJ, Duschinsky R , Lawlor ER et al (2022) . BMJ Open, 12(4).
• Kersbergen I, Buykx P, Brennan A, Brown J, Michie S & Holmes J (2022) . Drug and Alcohol Review, 41(5), 1161-1173.
• Bates SE, Thomas C, Islam N, Ahern AL, Breeze P, Griffin S & Brennan A (2022) . BMC Public Health, 22(1).
• Søholm U, Broadley M, Zaremba N, Divilly P, Nefs G, Mahmoudi Z, de Galan B, Pedersen-Bjergaard U, Brennan A, Pollard DJ , McCrimmon RJ et al (2022) . BMJ Open, 12(2).
• Richards R, Jones RA, Whittle F, Hughes CA, Hill AJ, Lawlor ER, Bostock J, Bates S, Breeze PR, Brennan A , Thomas CV et al (2022) . Jmir Formative Research, 6(1).
• Buckley C, Field M, Vu TM, Brennan A, Greenfield TK, Meier PS, Nielsen A, Probst C, Shuper PA & Purshouse RC (2022) . Addictive Behaviors, 124.
• Tew M, Willis M, Asseburg C, Bennett H, Brennan A, Feenstra T, Gahn J, Gray A, Heathcote L, Herman WH , Isaman D et al (2022) . Medical Decision Making, 42(5), 599-611.
• Flight L, Julious S, Brennan A & Todd S (2022) . Medical Decision Making, 42(4), 461-473.
• Opazo Breton M, Gillespie D, Pryce R, Bogdanovica I, Angus C, Hernandez Alava M, Brennan A & Britton J (2022) . Addiction, 117(5), 1392-1403.
• Bates S, Norman P, Breeze P, Brennan A & Ahern A (2022) . Annals of Behavioral Medicine, 56(1), 64-77.
• Penn L, Rodrigues A, Haste A, Marques MM, Budig K, Sainsbury K, Bell R, Araújo-Soares V, White M, Summerbell C , Goyder E et al (2022) . BMJ Open, 8(2).
• Khunti K, Griffin S, Brennan A, Dallosso H, Davies M, Eborall H, Edwardson C, Gray L, Hardeman W, Heathcote L , Henson J et al (2021) . Health Technology Assessment, 25(77).
• Langley T, Gillespie D, Lewis S, Eminson K, Brennan A, Docherty G & Young B (2021) . Journal of Public Health, 43(3), 639-646.
• Battisti NML, Hatton MQ, Reed MWR, Herbert E, Morgan JL, Bradburn M, Simcock R, Walters SJ, Collins KA, Ward SE , Holmes GR et al (2021) . Radiotherapy and Oncology, 161, 166-176.
• Purshouse RC, Buckley C, Brennan A & Holmes J (2021) . Addiction, 116(10), 2709-2711.
• Khunti K, Griffin S, Brennan A, Dallosso H, Davies MJ, Eborall HC, Edwardson CL, Gray LJ, Hardeman W, Heathcote L , Henson J et al (2021) . BMC Medicine, 19.
• Ring A, Battisti NML, Reed MWR, Herbert E, Morgan JL, Bradburn M, Walters SJ, Collins KA, Ward SE, Holmes GR , Burton M et al (2021) . British Journal of Cancer, 125(2), 209-219.
• Holmes GR, Ward SE, Brennan A, Bradburn M, Morgan JL, Reed MWR, Richards P, Rafia R, Wyld L, Burton M , Lifford K et al (2021) . Value in Health, 24(6), 770-779.
• Rehm J, Patra J, Brennan A, Buckley C, Greenfield TK, Kerr WC, Manthey J, Purshouse RC, Rovira P, Shuper PA & Shield KD (2021) . Drug and Alcohol Review, 40(7), 1377-1386.
• Morgan JL, Shrestha A, Reed MWR, Herbert E, Bradburn M, Walters SJ, Martin C, Collins K, Ward S, Holmes G , Burton M et al (2021) . British Journal of Surgery, 108(3), 315-325.
• Meier PS, Holmes J, Brennan A & Angus C (2021) . Addiction, 116(9), 2372-2384.
• Patra J, Buckley C, Kerr WC, Brennan A, Purshouse RC & Rehm J (2021) . Drug and Alcohol Review, 40(6), 1061-1070.
• Brennan A, Angus C, Pryce R, Buykx P, Henney M, Gillespie D, Holmes J & Meier PS (2021) . Public Health Research, 9(4).
• Wilson LB, Angus C, Pryce R, Holmes J, Brennan A & Gillespie D (2021) . Addiction, 116(9), 2538-2547.
• Battisti NML, Reed MWR, Herbert E, Morgan JL, Collins KA, Ward SE, Holmes GR, Bradburn M, Walters SJ, Burton M , Lifford K et al (2021) . European Journal of Cancer, 144, 269-280.
• Wilson LB, Pryce R, Angus C, Hiscock R, Brennan A & Gillespie D (2021) . The European Journal of Health Economics, 22(3), 381-392.
• Coates E, Amiel S, Baird W, Benaissa M, Brennan A, Campbell M, Chadwick P, Chater T, Choudhary P, Cooke D , Cooper C et al (2021) . BMJ Open, 11(1).
• Horton M, Perman-Howe PR, Angus C, Bishop J, Bogdanovica I, Brennan A, Britton J, Brose LS, Brown J, Collin J , Dockrell M et al (2021) . Wellcome Open Research, 6.
• Gillespie D, Hatchard J, Squires H, Gilmore A & Brennan A (2021) . BMC Public Health, 21.
• Wyld L, Reed MWR, Morgan J, Collins K, Ward S, Holmes GR, Bradburn M, Walters S, Burton M, Herbert E , Lifford K et al (2021) . European Journal of Cancer, 142, 48-62.
• Moore S, Young T, Irving A, Goodacre S, Brennan A & Amos Y (2021) . Emergency Medicine Journal, 38(7), 504-510.
• Wilson LB, Pryce R, Hiscock R, Angus C, Brennan A & Gillespie D (2021) . Tobacco Control, 30(e1), e27-e32.
• Angus C, Pryce R, Holmes J, de Vocht F, Hickman M, Meier P, Brennan A & Gillespie D (2020) . Addiction, 115(12), 2268-2279.
• Schneider PP, Smith RA, Bullas AM, Quirk H, Bayley T, Haake SJ, Brennan A & Goyder E (2020) . Public Health, 189, 48-53.
• Vocht F, McQuire C, Brennan A, Egan M, Angus C, Kaner E, Beard E, Brown J, De Angelis D, Carter N , Murray B et al (2020) . Addiction, 115(11), 2021-2031.
• Holmes J, Beard E, Brown J, Brennan A, Meier PS, Michie S, Stevely AK, Webster L & Buykx PF (2020) . Journal of Epidemiology and Community Health, 74(11), 942-949.
• Breeze P, Thomas C, Thokala P, LaFortune L, Brayne C & Brennan A (2020) . Medical Decision Making, 40(7), 912-923.
• Holmes J, Beard E, Brown J, Brennan A, Kersbergen I, Meier PS, Michie S, Stevely AK & Buykx P (2020) . Public Health Research, 8(14).
• Thomas C, Brennan A, Goka E, Squires H, Brenner G, Bagguley D, Buckley Woods H, Gillett M, Leaviss J, Clowes M , Heathcote L et al (2020) . BMJ Open, 10(9).
• Si L, Willis MS, Asseburg C, Nilsson A, Tew M, Clarke PM, Lamotte M, Ramos M, Shao H, Shi L , Zhang P et al (2020) . Value in Health, 23(9), 1163-1170.
• Churchill S, Angus C, Purshouse R, Brennan A & Sherk A (2020) . Statistical Methods in Medical Research, 29(9), 2637-2646.
• Brennan A, Buckley C, Vu TM, Probst C, Nielsen A, Bai H, Broomhead T, Greenfield T, Kerr W, Meier PS , Rehm J et al (2020) . International Journal of Microsimulation, 13(2), 21-60.
• Moore S, Allen D, Amos Y, Blake J, Brennan A, Buykx P, Goodacre S, Gray L, Irving A, O'Cathain A , Sivarajasingam V et al (2020) . Health Services and Delivery Research, 8(24).
• Vu TM, Buckley C, Bai H, Nielson A, Probst C, Brennan A, Shuper P, Strong M & Purshouse R (2020) . Complexity, 2020.
• Thokala P, Dodd P, Baalbaki H, Brennan A, Dixon S & Lowrie K (2020) . Value in Health, 23(6), 743-750.
• Winkley K, Upsher R, Stahl D, Pollard D, Kasera A, Brennan A, Heller S & Ismail K (2020) . Health Technology Assessment, 24(28).
• Kunst N, Wilson ECF, Glynn D, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Goldhaber-Fiebert JD, Jackson C, Jalal H , Menzies NA et al (2020) . Value in Health, 23(6), 734-742.
• Vu T, Probst C, Nielsen A, Bai H, Buckley C, Meier P, Strong M, Brennan A & Purshouse R (2020) . Journal of Artificial Societies and Social Simulation, 23(3).
• Jiang H, Livingston M, Room R, Callinan S, Marzan M, Brennan A & Doran C (2020) . Addiction, 115(6), 1038-1049.
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S & Ismail K (2020) . Diabetic Medicine, 37(5), 735-746.
• Ahern AL, Woolston J, Wells E, Sharp SJ, Islam N, Lawlor ER, Duschinsky R, Hill AJ, Doble B, Wilson E , Morris S et al (2020) . BMJ Open, 10(4).
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller SR & Ismail K (2020) . BMJ Open Diabetes Research & Care, 8(1).
• Probst C, Vu TM, Epstein JM, Nielsen AE, Buckley C, Brennan A, Rehm J & Purshouse RC (2020) . Health Education and Behavior, 47(2), 224-234.
• Flight L, Julious S, Brennan A, Todd S & Hind D (2020) . Trials, 21(1).
• Kearns B, Stevens J, Ren S & Brennan A (2020) . PharmacoEconomics, 38(2), 193-204.
• Pryce R, Angus C, Holmes J, Gillespie D, Buykx P, Meier P, Hickman M, de Vocht F & Brennan A (2020) . Population Health Metrics, 18(1).
• Bates S, Bayley T, Norman P, Breeze P & Brennan A (2020) . Medical Decision Making, 40(1), 90-105.
• Holmes J, Beard E, Brennan A, Brown J, Gillespie D, Meier PS, Michie S, Stevely AK, Webster L & Buykx P (2019) . The Lancet, 394, S54-S54.
• Meier P, Purshouse R, Bain M, Bambra C, Bentall R, Birkin M, Brazier J, Brennan A, Bryan M, Cox J , Fell G et al (2019) . Wellcome Open Research, 4.
• Marchand R, Genovese A, Koh SCL & Brennan A (2019) . Energy Policy, 130, 206-217.
• Jiang H, Room R, Livingston M, Callinan S, Brennan A, Doran C & Thorn M (2019) . BMJ Open, 9(6).
• Flight L, Arshad F, Barnsley R, Patel K, Julious S, Brennan A & Todd S (2019) . Value in Health, 22(4), 391-398.
• Holmes J, Angus C, Meier PS, Buykx P & Brennan A (2019) . Addiction, 114(4), 607-608.
• Brennan A, Hill-McManus D, Stone T, Buykx P, Ally A, Pryce RE, Alston R, Jones A, Cairns D, Millar T , Donmall M et al (2019) . Journal of Studies on Alcohol and Drugs(Sup 18), 96-109.
• Di Tanna GL, Porter JK, Lipton RB, Brennan A, Palmer S, Hatswell AJ, Sapra S & Villa G (2019) . BMC Medical Research Methodology, 19.
• Angus C, Li J, Romero-Rodriguez E, Anderson P, Parrott S & Brennan A (2019) . European Journal of Public Health, 29(2), 219-225.
• Holmes J, Angus C, Meier PS, Buykx P & Brennan A (2019) . Addiction, 114(4), 590-600.
• Gavens L, Holmes J, Buykx P, de Vocht F, Egan M, Grace D, Lock K, Mooney JD & Brennan A (2019) . Health & Place, 57, 358-364.
• Bhattacharya A, Angus C, Pryce R, Holmes J, Brennan A & Meier PS (2018) . Addiction, 113(12), 2225-2232.
• Addison M, Mcgovern R, Angus C, Becker F, Brennan A, Brown H, Coulton S, Crowe L, Gilvarry E, Hickman M , Howel D et al (2018) . Alcohol and Alcoholism, 53(5), 548-559.
• Lipton RB, Brennan A, Palmer S, Hatswell AJ, Porter JK, Sapra S, Villa G, Shah N, Tepper S & Dodick D (2018) . Journal of Medical Economics (JME), 21(7), 666-675.
• de Vocht F, Angus C, Tilling K, Brennan A & Hickman M (2018) . Journal of Epidemiology and Community Health, 72(9), 864-864.
• Palmer AJ, Si L, Tew M, Hua X, Willis MS, Asseburg C, McEwan P, Leal J, Gray A, Foos V , Lamotte M et al (2018) . Value in Health, 21(6), 724-731.
• Breeze P, Womack R, Pryce R, Brennan A & Goyder E (2018) . PLoS One, 13(5).
• Pollard DJ, Brennan A, Dixon S, Waugh N, Elliott J, Heller S, Lee E, Campbell M, Basarir H & White D (2018) . BMJ Open, 8.
• Holmes J, Meier PS, Angus C & Brennan A (2018) . Addiction, 113(2), 203-204.
• Purshouse RC, Brennan A, Holmes J & Meier PS (2018) . Addiction, 113(2), 372-373.
• Grimm SE, Strong M, Brennan A & Wailoo A (2017) . PharmacoEconomics, 35(1), 1287-1296.
• Meier P, Brennan A, Angus C & Holmes J (2017) . BMJ, 359.
• Salleh S, Thokala P, Brennan A, Hughes R & Dixon S (2017) . Pharmacoeconomics, 35, 989-1006.
• de Vocht F, Tilling K, Pliakas T, Angus C, Egan M, Brennan A, Campbell R & Hickman M (2017) . Journal of Epidemiology and Community Health, 71(9), 912-918.
• Salleh S, Thokala P, Brennan A, Hughes R & Booth A (2017) . PharmacoEconomics, 35, 937-949.
• Thomas C, Sadler S, Breeze P, Squires H, Gillett M & Brennan A (2017) . BMJ Open, 7.
• Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle P, Brunner E, Tabak A, Preston L & Chilcott J (2017) . Diabetic Medicine, 34(8), 1136-1144.
• Purshouse RC, Brennan A, Moyo D, Nicholls J & Norman P (2017) . Alcohol and Alcoholism, 52(3), 372-381.
• Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle PJ, Brunner E, Tabak A, Preston L & Chilcott J (2017) . Diabetic Medicine, 34(5), 632-640.
• Angus CR, Holmes J, Maheswaran R, Green M, Meier P & Brennan A (2017) . International Journal of Environmental Research and Public Health, 14(4).
• Sadler S, Angus C, Gavens L, Gillespie D, Holmes J, Hamilton J, Brennan A & Meier P (2017) . Addiction, 112(5), 808-817.
• Heller S, White D, Lee E, Lawton J, Pollard D, Waugh N, Amiel S, Barnard K, Beckwith A, Brennan A , Campbell M et al (2017) . Health Technology Assessment, 21(20), 1-278.
• Angus CR, Thomas C, Anderson P, Meier P & Brennan A (2017) . European Journal of Public Health, 27(2), 345-351.
• Heller S, Amiel S, Campbell M, Choudhary P, Cooper C, Dimairo M, Elliott J, Hammond P, Lee E, Lindsay R , Waugh N et al (2017) . BMJ, 356.
• De Vocht F, Heron J, Campbell R, Egan M, Mooney JD, Angus C, Brennan A & Hickman M (2017) . Journal of Epidemiology and Community Health, 71, 137-145.
• Breeze P, Squires H, Chilcott J, Stride C, Diggle PJ, Brunner E, Tabak A & Brennan A (2016) . Journal of Public Health, 38(4), 679-687.
• Peasgood T, Brennan A, Mansell P, Elliott J, Basarir H & Kruger J (2016) . Medical Decision Making, 38(8), 1020-1033.
• Thomas C, Breeze P, Strong M, Brennan A, Norman P, Cameron D & Epton T (2016) . Journal of Public Health & Epidemiology, 8(10), 191-203.
• Basarir H, Brennan A, Jacques RM, Pollard D, Stevens K, Freeman J, Wales J & Price K (2016) . International Journal of Technology Assessment in Health Care, 32(4), 203-211.
• Beard E, Brown J, West R, Angus C, Brennan A, Holmes J, Kaner E, Meier P & Michie S (2016) . PLoS One, 11(9).
• de Vocht F, Brown J, Beard E, Angus C, Brennan A, Michie S, Campbell R & Hickman M (2016) . BMC Public Health, 16, 917.
• Egan M, Brennan A, Buykx P, De Vocht F, Gavens L, Grace D, Halliday E, Hickman M, Holt V, Mooney JD & Lock K (2016) . Health and Place, 41, 11-18.
• Rafia R, Dodd PJ, Brennan A, Meier PS, Hope VD, Ncube F, Byford S, Tie H, Metrebian N, Hellier J , Weaver T et al (2016) . Addiction, 111(9), 1616-1627.
• Ally AK, Lovatt M, Meier PS, Brennan A & Holmes J (2016) . Addiction, 111(9), 1568-1579.
• Graham J, McBride D, Stull D, Halliday A, Alexopoulos ST, Balp MM, Griffiths M, Agirrezabal I, Zuberbier T & Brennan A (2016) . Pharmacoeconomics, 34(8), 815-827.
• Brown J, West R, Beard E, Brennan A, Drummond C, Gillespie D, Hickman M, Holmes J, Kaner E & Michie S (2016) . BMC Public Health, 16.
• Rafia R, Brennan A, Madan J, Collins K, Reed MWR, Lawrence G, Robinson T, Greenberg D & Wyld L (2016) . Value in Health, 19(4), 404-412.
• de Vocht F, Heron J, Angus C, Brennan A, Mooney J, Lock K, Campbell R & Hickman M (2016) . Journal of Epidemiology and Community Health, 70(3), 231-237.
• Meier PS, Holmes J, Angus C, Ally AK, Meng Y & Brennan A (2016) . PLoS Medicine, 13(2).
• Brown J, West R, Angus C, Beard E, Brennan A, Drummond C, Hickman M, Holmes J, Kaner E & Michie S (2016) . British Journal of General Practice , 66(642), e1-e9.
• (2016) . Diabetic Medicine, 33(8), 1155-1163.
• Price KJ, Knowles JA, Fox M, Wales JKH, Heller S, Eiser C, Freeman JV, Brennan A, Basirir H, Stevens K & McPherson A (2016) . Diabetic Medicine, 33(2), 192-203.
• Lawton J, Kirkham J, Rankin D, White DA, Elliott J, Jaap A, Smithson WH, Heller S, Gianfrancesco C, Gordon V , Greaves L et al (2016) . Diabetic Medicine, 33(2), 243-251.
• Cameron D, Epton T, Norman P, Sheeran P, Harris PR, Webb TL, Julious SA, Brennan A, Thomas C, Petroczi A , Naughton D et al (2015) . Trials, 16(1).
• Kruger J, Pollard DJ, Basarir H, Thokala P, Cooke D, Clark M, Bond R, Heller S & Brennan A (2015) . Medical Decision Making, 35(7), 872-887.
• Brennan A, Meier P, Purshouse R, Rafia R, Meng Y, Hill-Macmanus D, Angus C & Holmes J (2015) . Health Economics, 24(10), 1368-1388.
• Strong M, Oakley JE, Brennan A & Breeze P (2015) . Medical Decision Making, 35(5), 570-583.
• Birch J, Scott S, Newbury-Birch D, Brennan A, Brown H, Coulton S, Gilvarry E, Hickman M, McColl E, McGovern R , Muirhead C et al (2015) . Pilot and Feasibility Studies, 1.
• Moyo D, Ally AK, Brennan A, Norman P, Purshouse RC & Strong M (2015) . Journal of Artificial Societies and Social Simulation, 18(3).
• Watson P, Brennan A, Birch H, Fang H & Petri M (2015) . Rheumatology, 54(4), 623-632.
• Breeze P & Brennan A (2014) . Health Economics.
• Heller S, Lawton J, Amiel S, Cooke D, Mansell P, Brennan A, Elliott J, Boote J, Emery C, Baird W , Basarir H et al (2014) . Programme Grants for Applied Research, 2(5).
• Ally AK, Meng Y, Chakraborty R, Dobson PW, Seaton JS, Holmes J, Angus C, Guo Y, Hill-McManus D, Brennan A & Meier PS (2014) . Addiction, 109(12), 1994-2002.
• Mooney JD, Holmes J, Brennan A, Meier PS, Hickman M & Lock K (2014) . The Lancet, 384, S52-S52.
• Holmes J, Meier PS, Booth A & Brennan A (2014) . Drug and Alcohol Review, 33(6), 596-603.
• Lawto J, Kirkham J, Rankin D, Barnard K, Cooper CL, Taylor C, Heller S, Elliott J & the REPOSE Group (2014) . Diabetes Research and Clinical Practice, 106(3), 443-450.
• Brennan A, Meng Y, Holmes J, Hill-McManus D & Meier PS (2014) . BMJ, 349(-), ---.
• Holmes J, Guo Y, Maheswaran R, Nicholls J, Meier PS & Brennan A (2014) . Drug and Alcohol Review, 33(5), 515-525.
• Purshouse RC, Ally AK, Brennan A, Moyo D & Norman P (2014) . Proceedings of the 2014 Annual Conference on Genetic and Evolutionary Computation, 1159-1166.
• Elliott J, Jacques RM, Kruger J, Campbell MJ, Amiel SA, Mansell P, Speight J, Brennan A & Heller SR (2014) . Diabet Med, 31(7), 847-853.
• Epton T, Norman P, Dadzie A-S, Harris PR, Webb TL, Sheeran P, Julious SA, Ciravegna F, Brennan A, Meier PS , Naughton D et al (2014) . Acta Veterinaria Scandinavica, 563-563.
• Watson P, Preston L, Squires H, Chilcott J & Brennan A (2014) . Appl Health Econ Health Policy, 12(3), 239-253.
• Holmes J, Meng Y, Meier PS, Brennan A, Angus C, Campbell-Burton A, Guo Y, Hill-McManus D & Purshouse RC (2014) . Lancet, 383(9929), 1655-1664.
• Strong M, Oakley JE & Brennan A (2014) . Medical Decision Making, 34(3), 311-326.
• Thokala P, Kruger J, Brennan A, Basarir H, Duenas A, Pandor A, Gillett M, Elliott J & Heller S (2014) . Diabet Med, 31(4), 477-486.
• Meng Y, Brennan A, Purshouse R, Hill-McManus D, Angus C, Holmes J & Meier PS (2014) . J Health Econ, 34(100), 96-103.
• Angus C, Scafato E, Ghirini S, Torbica A, Ferre F, Struzzo P, Purshouse R & Brennan A (2014) . BMC Fam Pract, 15, 26.
• Meng Y, Holmes J, Hill-McManus D, Brennan A & Meier PS (2014) . Addiction, 109(2), 206-215.
• Kruger J, Brennan A, Strong M, Thomas C, Norman P & Epton T (2014) . Annals of Surgical Innovation and Research, 14.
• Hill-McManus D, Angus C, Meng Y, Holmes J, Brennan A & Sylvia Meier P (2014) . Drug and Alcohol Dependence, 134(1), 136-143.
• Strong M, Brennan A & Oakley J (2013) . Trials, 14(S1).
• Richards P & Brennan A (2013) . Trials, 14(S1).
• Thokala P, Baalbaki H, Brennan A, Pandor A, Stevens JW, Gomersall T, Wang J, Bakhai A, Al-Mohammad A, Cleland J , Cowie MR et al (2013) . BMJ Open, 3(9), e003250.
• Kruger J, Brennan A, Thokala P, Basarir H, Jacques R, Elliott J, Heller S & Speight J (2013) . DIABETIC MEDICINE, 30(10), 1236-1244.
• Pandor A, Thokala P, Gomersall T, Baalbaki H, Stevens JW, Wang J, Wong R, Brennan A & Fitzgerald P (2013) . Health Technol Assess, 17(32), 1-vi.
• Tappenden P, Chilcott J, Brennan A, Squires H, Glynne-Jones R & Tappenden J (2013) . Value in Health.
• Meier PS, Meng Y, Holmes J, Baumberg B, Purshouse R, Hill-McManus D & Brennan A (2013) . Alcohol Alcohol, 48(2), 241-249.
• Purshouse RC, Brennan A, Rafia R, Latimer NR, Archer RJ, Angus CR, Preston LR & Meier PS (2013) . Alcohol Alcohol, 48(2), 180-188.
• Epton T, Norman P, Sheeran P, Harris PR, Webb TL, Ciravegna F, Brennan A, Meier P, Julious SA, Naughton D , Petroczi A et al (2013) . BMC Public Health, 13, 107.
• Price KJ, Wales J, Eiser C, Knowles J, Heller S, Freeman J, Brennan A, McPherson A & Wellington J (2013) . BMJ Open, 3(1).
• Tosh J, Ben K, Brennan A, Parry G, Ricketts T, Saxon D, Kilgarriff-Foster A, Thake A, Chambers E & Hutten R (2013) Innovation in Health Economic Modelling of Service Improvements for Longer-Term Depression: Demonstration in a Local Health Community. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 16, S34-S35.
• Kruger J, Brennan A, Thokala P, Basarir H & Heller S (2013) The cost-effectiveness of Dose Adjustment for Normal Eating (DAFNE) structured education in Type 1 diabetes: an update using the Sheffield Type 1 diabetes policy model. DIABETIC MEDICINE, 30, 133-134.
• Norman P, Epton T, Dadzie A-S, Sheeran P, Harris P, Webb T, Ciravegna F, Julious S, Brennan A, Meier P , Kruger J et al (2013) A theory-based online intervention to promote health behaviour in new university students: One-month follow-up data. PSYCHOLOGY & HEALTH, 28, 132-132.
• Tosh J, Kearns B, Brennan A, Parry G, Ricketts T, Saxon D, Kilgarriff-Foster A, Thake A, Chambers E & Hutten R (2013) . BMC Health Serv Res, 13, 150.
• Kruger J & Brennan A (2013) . Eur J Health Econ, 14(6), 887-899.
• Tappenden P, Chilcott J, Brennan A, Squires H & Stevenson M (2012) . Value Health, 15(8), 1127-1136.
• Karnon J, Stahl J, Brennan A, Caro JJ, Mar J & Möller J (2012) . Medical Decision Making, 32(5), 701-711.
• Karnon J, Stahl J, Brennan A, Caro JJ, Mar J & Möller J (2012) . Value in Health, 15(6), 821-827.
• Gillett M, Royle P, Snaith A, Scotland G, Poobalan A, Imamura M, Black C, Boroujerdi M, Jick S, Wyness L , McNamee P et al (2012) . Health Technol Assess, 16(33), 1-iv.
• Holmes J, Meier PS, Booth A, Guo Y & Brennan A (2012) . Drug and Alcohol Dependence, 123(1-3), 7-14.
• Tosh J, Brennan A, Wailoo A & Bansback N (2011) . Rheumatology (Oxford), 50 Suppl 4, iv26-iv31.
• Meier P & Brennan A (2011) . Journal of Epidemiology and Community Health, 65(Suppl 1), A47.4-A47.
• Kharroubi SA, Brennan A & Strong M (2011) . Med Decis Making, 31(6), 839-852.
• Nagy B, Brennan A, Brandtmüller A, Thomas SK, Sullivan SD & Akehurst R (2011) . Int J Geriatr Psychiatry, 26(5), 483-494.
• Gillett M, Dixon S, Dallosso HM, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K, Skinner TC & Davies MJ (2010) . BRIT MED J, 341.
• Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K, Skinner TC & Davies MJ (2010) . BMJ, 341, c4093.
• Karnon J, Brennan A & Akehurst R (2010) . MED DECIS MAKING, 30(3), E20-E22.
• Purshouse RC, Meier PS, Brennan A, Taylor KB & Rafia R (2010) . Lancet, 375(9723), 1355-1364.
• Oakley JE, Brennan A, Tappenden P & Chilcott J (2010) . J Health Econ, 29(3), 468-477.
• Meier PS, Purshouse R & Brennan A (2010) . Addiction, 105(3), 400-401.
• Meier PS, Purshouse R & Brennan A (2010) . Addiction, 105(3), 383-393.
• Karnon J, Holmes MW, Williams R, Bakhai A & Brennan A (2010) . INT J CARDIOL, 140(3), 315-322.
• Tappenden P, Chilcott J, Brennan A & Pilgrim H (2009) . Int J Technol Assess Health Care, 25(4), 470-478.
• Brennan A, Nagy B, Brandtmüller A, Thomas SK, Gallagher M, Sullivan SD & Akehurst R (2009) . Aktuelle Neurologie, 36(S 02).
• Nagy B, Brennan A, Brandtmüller A, Thomas SK, Gallagher M, Sullivan SD & Akehurst R (2009) . Aktuelle Neurologie, 36(S 02).
• Stevenson MD, Oakley JE, Lloyd Jones M, Brennan A, Compston JE, McCloskey EV & Selby PL (2009) . Med Decis Making, 29(6), 678-689.
• Nixon RM, O'Hagan A, Oakley J, Madan J, Stevens JW, Bansback N & Brennan A (2009) . PHARM STAT, 8(4), 371-389.
• Nixon RM, Bansback N, Stevens JW, Brennan A & Madan J (2009) . PHARM STAT, 8(2), 150-162.
• Nagy B, Brennan A, Brandtmuller A, Thomas S, Gallagher M, Sullivan SD & Akehurst R (2008) . Alzheimer's & Dementia, 4(4S_Part_14).
• Bansback N, Brennan A, Symmons D, Nixon R, Madan J, Harrison M & Watson K (2008) . RHEUMATOLOGY, 47(7), 1107-1107.
• Hadwin R, Eggington S, Brennan A, Walker P, Patnick J & Pilgrim H (2008) . BJOG-INT J OBSTET GY, 115(6), 749-757.
• Wailoo AJ, Bansback N, Brennan A, Michaud K, Nixon RM & Wolfe F (2008) . Arthritis Rheum, 58(4), 939-946.
• Wailoo AJ, Sutton AJ, Cooper NJ, Turner DA, Abrams KR, Brennan A & Nicholson KG (2008) . Value Health, 11(2), 160-171.
• Brennan A, Kharroubi S, O'hagan A & Chilcott J (2007) . Med Decis Making, 27(4), 448-470.
• Karnon J, Brennan A & Akehurst R (2007) . Med Decis Making, 27(4), 491-499.
• Palmer AJ, Roze S, Valentine WJ, McEwan P, Gillett M, Holmes M, Clarke P, Stevens R, Gray AM, Coleman R , Sorensen S et al (2007) . DIABETES CARE, 30(6), 1638-1646.
• Brennan A, Bansback N, Nixon R, Madan J, Harrison M, Watson K & Symmons D (2007) . Rheumatology (Oxford), 46(8), 1345-1354.
• Nixon R, Bansback N & Brennan A (2007) . RHEUMATOLOGY, 46(7), 1140-1147.
• Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R & John A (2007) Screening for type 2 diabetes: Literature review and economic modelling. Health Technology Assessment, 11(17).
• Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R & John A (2007) Screening for type 2 diabetes: literature review and economic modelling. HEALTH TECHNOL ASSES, 11(17), 1-+.
• Brennan A & Kharroubi SA (2007) . Health Econ, 16(11), 1205-1225.
• Ara R & Brennan A (2007) . Obes Rev, 8(4), 363-371.
• Brennan A, Akehurst R, Davis S, Sakai H & Abbott V (2007) . Value Health, 10(1), 32-41.
• Brennan A & Kharroubi SA (2007) . J Health Econ, 26(1), 122-148.
• Nixon RM, Bansback N & Brennan A (2007) . STAT MED, 26(6), 1237-1254.
• Brennan A, Ara R, Sterz R, Matiba B & Bergemann R (2006) . Eur J Health Econ, 7(4), 276-284.
• Brennan A, Chick SE & Davies R (2006) . Health Econ, 15(12), 1295-1310.
• Bansback N, Young A, Brennan A & Dixey J (2006) A prognostic model for functional outcome in early rheumatoid arthritis. Journal of Rheumatology, 33(8), 1503-1510.
• Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E, Young G, Rothwell P, Roditi G , Gough M et al (2006) Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technology Assessment, 10(30).
• Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E, Young G, Rothwell P, Roditi G , Gough M et al (2006) Accurate, practical and cost-effective assessment of carotid stenosis in the UK. HEALTH TECHNOL ASSES, 10(30), 1-+.
• Bansback NJ, Ara R, Barkham N, Brennan A, Fraser AD, Conway P, Reynolds A & Emery P (2006) . Rheumatology (Oxford), 45(8), 1029-1038.
• Karnon J, Bakhai A, Brennan A, Pandor A, Flather M, Warren E, Gray D & Akehurst R (2006) . Int J Cardiol, 109(3), 307-316.
• Bansback N, Brennan A & Anis AH (2005) . Expert Rev Pharmacoecon Outcomes Res, 5(5), 519-529.
• Nuijten M, O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M , Spiegelhalter D et al (2005) . Pharmacoeconomics, 23(8), 851-853.
• O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M, Spiegelhalter D & Willan A (2005) Incorporation of uncertainty in health economic modelling studies - The authors' reply. PHARMACOECONOMICS, 23(8), 853-853.
• O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M, Spiegelhalter D & Willan A (2005) . Pharmacoeconomics, 23(6), 529-536.
• Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH & Marra CA (2005) . Drugs, 65(4), 473-496.
• Brazier J, Akehurst R, Brennan A, Dolan P, Claxton K, McCabe C, Sculpher M & Tsuchyia A (2005) . Appl Health Econ Health Policy, 4(4), 201-208.
• Brennan A, Sampson F & Deverill M (2005) . Health Serv Manage Res, 18(4), 265-276.
• O'Hagan A, McCabe C, Akehurst R, Brennan A, Briggs A, Claxton K, Fenwick E, Fryback D, Sculpher M, Spiegelhalter D & Willan A (2005) The Authors' Reply. PharmacoEconomics, 23(8), 853-853.
• Karnon J, Brennan A, Pandor A, Fowkes G, Lee A, Gray D, Coshall C, Nicholls C & Akehurst R (2005) . Curr Med Res Opin, 21(1), 101-112.
• Bansback NJ, Brennan A & Ghatnekar O (2005) . Ann Rheum Dis, 64(7), 995-1002.
• Bansback NJ, Young A & Brennan A (2005) . RHEUMATOLOGY, 44(1), 3-4.
• Bansback N, Brennan A, Sengupta N & Pang F (2004) THE COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRA (TM)) IN PATIENTS WITH RHEUMATOID ARTHRITIS: A UK ANALYSIS. RHEUMATOLOGY, 43, 77-77.
• Bansback N, Brennan A, Young A, Sollymossy C, Dixey J & Dart H (2004) WHICH PATIENTS WITH EARLY RA DEVELOP FAST PROGRESSIVE DISEASE? PROGNOSTIC FACTORS FOR SEVERE FUNCTIONAL LOSS FROM AN INCEPTION COHORT WITH 9 YEAR FOLLOW UP. RHEUMATOLOGY, 43, 137-137.
• Brennan A & Bansback N (2004) . RHEUMATOLOGY, 43(5), 677-678.
• Warren E, Brennan A & Akehurst R (2004) . Med Decis Making, 24(1), 9-19.
• Brennan A, Bansback N, Reynolds A & Conway P (2004) . Rheumatology (Oxford), 43(1), 62-72.
• Karnon J, Brennan A & Chilcott J (2003) . Eur J Health Econ, 4(3), 239-240.
• Chilcott J, Brennan A, Booth A, Karnon J & Tappenden P (2003) The role of modelling in prioritising and planning clinical trials.. Health technology assessment (Winchester, England), 7(23).
• Dixon S, Coleman P, Nicholl J, Brennan A & Touch S (2003) . Journal of Health Services Research & Policy, 8(1), 18-24.
• Dixon S, Coleman P, Nicholl J, Brennan A & Touch S (2003) . J Health Serv Res Policy, 8(1), 18-24.
• Brennan A, Bansback N, Conway P & Reynolds A (2002) MODELLING THE COST-EFFECTIVENESS OF ETANERCEPT IN ADULTS WITH RHEUMATOID ARTHRITIS IN THE UK. RHEUMATOLOGY, 41, 91-91.
• Stevenson M, Beard S, Finn A & Brennan A (2002) . Vaccine, 20(13-14), 1778-1786.
• Cornell SJ, Chilcott JB & Brennan A (2001) . J Epidemiol Community Health, 55(7), 521-527.
• Stevenson MD, Oakley PA, Beard SM, Brennan A & Cook AL (2001) . Injury, 32(4), 267-274.
• Brennan A & Akehurst R (2000) . Pharmacoeconomics, 17(5), 445-459.
• Degeling K, Karnon J, van de Ven M, Brennan A & Koffijberg H () . Applied Health Economics and Health Policy.
• Masuku SD, Mandrik O, Mdege N, Mishra G, Meyer-Rath G, Lince-Deroche N & Brennan A () Breast cancer screening using clinical breast examination: A cost-effectiveness analysis for South Africa. Value in Health Regional Issues.
• Pollard D, Keetharuth A, Brennan A, Bodicoat DH, Glab A, Hadjiconstantinou M, Mensa J, Northern A & Davies MJ () A model based cost-utility analysis of embedding referral to structured self-management education into standard practice (Embedding) compared to usual care for people with type 2 diabetes diagnosis in the last 12 months in England.. BMJ Open.
• Brennan A, Meier P, Purshouse R, Rafia R, Meng Y & Hill-Macmanus D () . Annals of Operations Research, 236(1), 149-176.
• de Vocht F, Campbell R, Brennan A, Mooney J, Angus C & Hickman M () . Public Health.
• Gillett M, Brennan A, Watson P, Khunti K, Davies M, Mostafa S & Gray LJ () . Health Technology Assessment, 19(33), 1-80.

Book chapters

• Grimm S, Brennan A & Heath A (2024) , Value of Information for Healthcare Decision Making (pp. 251-263).
• Grimm S, Brennan A & Heath A (2023) , Value of Information for Healthcare Decision-Making (pp. 251-264). Chapman and Hall/CRC
• Payne N, Akehurst R, Beard S, Brennan A, Calvert N, Chilcott J, Mccabe C, Paisley S & Ward S (2017) Supporting purchasing in acute specialties in the trent region, Controlling Costs Strategic Issues in Health Care Management (pp. 118-130).
• Heath A, Kunst N & Jackson C () Chapman and Hall/CRC

Conference proceedings

• Mueller J, Evans T, Breeze P, Spreckley M, Brennan A, Hill A, Hughes C, Valabhji J, Sharp S, Duschinsky R , Patel H et al (2025) . International Journal of Obesity, Vol. 49(Suppl 1) (pp 1-45). Aberdeen, Scotland, 10 September 2025 - 10 September 2025.
• Tian D, Squires H, Buckley C, Gillespie D, Tattan-Birch H, Shahab L, West R, Brennan A, Brown J & Purshouse R (2025) . 2024 Winter Simulation Conference (WSC) (pp 252-263). Orlando, Florida, 15 December 2024 - 15 December 2024.
• Bates S, Saidi Y, Cookson R, Skarda I, Ford T, Ganguli P, Byford S, Hayes R & Brennan A (2024) . SSM Annual Scientific Meeting (pp A63.1-A63)
• Heath A, Brennan A & Grimm S (2024) HEALTH TECHNOLOGY DECISION-MAKING IN AN IMPERFECT WORLD: A UNIFYING FRAMEWORK OF VALUE OF INFORMATION AND IMPLEMENTATION METRICS BASED ON A NARRATIVE REVIEW. VALUE IN HEALTH, Vol. 27(12) (pp S471-S472)
• Mueller J, Breeze P, Griffin S, Brennan A, Hill A, Morris S, Hughes CA, Woolston J, Lachassseigne E, Stubbings M , Sharp S et al (2023) . Obesity, Vol. 31(S2) (pp 47-48). Dallas, Texas, 14 October 2023 - 14 October 2023.
• Hoehn A, Lomax N, Rice H, Angus C, Brennan A, Brown D, Comrie E, Elsenbroich C, Hughes C & Katikireddi SV (2023) . SSM Annual Scientific Meeting (pp A18.2-A19)
• Mensah J, Thomas C, Akparibo R & Brennan A (2023) PUBLIC HEALTH ECONOMIC MODELLING IN EVALUATIONS OF SALT AND ALCOHOL POLICIES: A SCOPING REVIEW. VALUE IN HEALTH, Vol. 26(12) (pp S544-S544)
• Bryning S, Jones GF, Pollit V & Brennan A (2022) WHEN IS A SIMPLE MODEL GOOD ENOUGH? TOWARDS GREATER USE OF FORMAL METHODS FOR EVALUATING STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS ANALYSIS. VALUE IN HEALTH, Vol. 25(7) (pp S350-S351)
• Holding E, Foster A, Lumley E, Brennan A, Gillett M & Goyder E (2021) . The Lancet, Vol. 398(Supplement 2) (pp S53-S53). Virtual conference, 25 November 2021 - 25 November 2021.
• Bates S, Breeze P, Norman P & Brennan A (2021) . The Lancet, Vol. 398(Supplement 2) (pp 23-23). Virtual conference, 26 November 2021 - 26 November 2021.
• Breeze P, Sworn K, Abraham S, McGrane E, Cantrell A & Brennan A (2021) . The Lancet, Vol. 398(Supplement 2) (pp S27-S27). Online, 26 November 2021 - 26 November 2021.
• Clarke AE, St-Pierre Y, Paly V, Bruce IN, Malmberg C, Briggs A, Zhang Y, Choi J & Brennan A (2021) . Annals of the Rheumatic Diseases, Vol. 80 (pp 617-618)
• Vu TM, Davies E, Buckley C, Brennan A & Purshouse RC (2021) . Evolutionary Multi-Criterion Optimization : EMO 2021 Proceedings, Vol. 12654 (pp 721-733). Shenzhen, China, 28 March 2021 - 28 March 2021.
• (2020) . Medical Decision Making, Vol. 40(1) (pp E1-E379)
• Kunst NR, Wilson ECF, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Glynn D, Goldhaber-Fiebert JD, Jackson C, Jalal H , Menzies NA et al (2020) . Medical Decision Making, Vol. 40(1) (pp E63-E64). Portland, Oregon, 20 October 2019 - 20 October 2019.
• Flight L, Julious S, Brennan A & Todd S (2020) METHODS FOR CHOOSING THE BEST DESIGN OF A CLINICAL TRIAL: IMPLEMENTING EXPECTED VALUE OF SAMPLE INFORMATION AND ADJUSTING FOR BIAS INDUCED BY A GROUP SEQUENTIAL DESIGN. MEDICAL DECISION MAKING, Vol. 40(1) (pp E188-E189)
• Hatchard J, Buykx P, Brennan A & Gillespie D (2019) . The Lancet, Vol. 394(Suppl 2) (pp S51-S51). London, UK, 29 November 2019 - 29 November 2019.
• Schneider PP, Smith R, Bullas A, Haake S, Brennan A & Goyder E (2019) . European Journal of Public Health, Vol. 29(Supplement_4)
• Pollard D, Brennan A, Coates L & Heller S (2019) . Value in Health, Vol. 22 (pp S584-S584)
• Brennan A & Pollard D (2019) . Value in Health, Vol. 22 (pp S577-S577)
• de Vocht F, McQuire C, Brennan A, Egan M, Angus C, Kaner E, Beard E, Brown J, Cummins S, De Angelis D , Carter N et al (2019) . The Lancet, Vol. 394 (pp S35-S35)
• O'Cathain A, Croot E, Duncan E, Rousseau N, Sworn K, Turner K, Yardley L & Hoddinott P (2019) . Trials, Vol. 20(Supplement 1) (pp 99-99). Brighton, UK, 6 October 2019 - 6 October 2019.
• Flight L, Hind D, Julious S, Brennan A & Todd S (2019) . Trials, Vol. 20(Supplement 1) (pp 109-109). Brighton, UK, 6 October 2019 - 6 October 2019.
• Vu TM, Probst C, Epstein JM, Brennan A, Strong M & Purshouse RC (2019) . Proceedings of the Genetic and Evolutionary Computation Conference (pp 1356-1363)
• Paly V, Brennan A, Mukherjee J, Alemao E, Napoli A, Sidhu M, Perdrizet J, Clarke AE, Bruce I & Briggs A (2019) . Value in Health, Vol. 22 (pp S374-S374)
• Purshouse RC, Vu T, Bai H, Buckley CM, Nielsen AE, Probst C & Brennan A (2019) ALCOHOL POLICY MODELING USING THEORY - A NEW COMPUTATIONAL PLATFORM FOR DEVELOPING MECHANISM-BASED EXPLANATORY MODELS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 43 (pp 142A-142A)
• Nielsen AE, Brennan A, Kerr W & Purshouse R (2019) SYNTHESIZING THE RATIONAL ADDICTION AND MYOPIC CHOICE ECONOMIC MODELS TO EXPLAIN POPULATION ALCOHOL USE AND UNDERSTAND PRICING POLICIES: AN AGENT-BASED SIMULATION. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 43 (pp 141A-141A)
• Pollard D, Brennan A, Coates L & Heller S (2019) PRETRIAL MODELLING METHODS TO JUSTIFY AND INFORM THE DESIGN OF LARGE RCTS - EXPECTED VALUE OF SAMPLE INFORMATION FOR THE DAFNEPLUS DIABETES EDUCATION CLUSTER RCT. VALUE IN HEALTH, Vol. 22 (pp S584-S584)
• Brennan A & Pollard D (2019) A HEALTH ECONOMIC AND DECISION MODELLING ANALYSIS PLAN FOR AN INTEGRATED DATABASE OF OVER 100 CLINICAL TRIALS MEASURING HYPOGLYCAEMIC ATTACKS FOR PEOPLE WITH DIABETES: A HEDMAP FOR HYPORESOLVE. VALUE IN HEALTH, Vol. 22 (pp S577-S577)
• Porter JK, Di Tanna GL, Lipton RB, Brennan A, Palmer S, Sapra S & Villa G (2018) . Value in Health, Vol. 21 (pp S206-S206)
• Purshouse RC, Nielsen A & Brennan A (2018) A CONCEPTUAL FRAMEWORK FOR MODELING ALCOHOL USE DYNAMICS OVER OPULATION HEALTH TIME HORIZONS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 42 (pp 331A-331A)
• Broomhead T, Purshouse R, Strong M, Brennan A, Kerr W, Greenfield T, Nielsen A & Probst C (2018) PLATFORM FOR CALIBRATED, SYSTEM-BASED MODELS OF ALCOHOL USE DYNAMICS. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 42 (pp 331A-331A)
• Brennan A, Pollard D, Coates L, Strong M & Heller S (2017) . Value in Health, Vol. 20(9) (pp A776-A776)
• Mooney JD, Holmes J, Gavens L, de Vocht F, Hickman M, Lock K & Brennan A (2017) . BMC Public Health, Vol. 17(825)
• Porter JK, Di Tanna GL, Villa G, Brennan A, Palmer S, Lipton RB, Jansen JP, Shah N, Desai P & Sapra S (2017) . Value in Health, Vol. 20(9) (pp A733-A733)
• Lipton RB, Brennan A, Palmer S, Jansen JP, Hatswell AJ, Porter JK, Di Tanna GL, Villa G, Shah N & Sapra S (2017) . Value in Health, Vol. 20(9) (pp A732-A732)
• Holloway AS, Ferguson J, Landale S, Cariola L, Newbury-Birch D, Flynn A, Knight JR, Sherritt L, Harris SK, O’Donnell AJ , Kaner E et al (2017) . Addiction science & clinical practice, Vol. 12(Suppl 1)
• Lipton RB, Porter JK, Shah N, Sapra S, Desai P, Villa G, Brennan A, Palmer S & Jansen J (2017) A comparison of approaches to model migraine day frequency in migraine. CEPHALALGIA, Vol. 37 (pp 102-103)
• Porter JK, Brennan A, Palmer S, Sapra S, Shah N, Desai P, Villa G & Lipton AB (2017) MODELING MIGRAINE DAY FREQUENCY USING THE BETA-BINOMIAL DISTRIBUTION: A CASE STUDY OF ERENUMAB AS MIGRAINE PROPHYLAXIS. VALUE IN HEALTH, Vol. 20(5) (pp A329-A329)
• Upsher RJ, Stahl D, Pollard D, Gillett M, Brennan A, Heller S, Ismail K & Winkley K (2017) A Systematic Review of Psychological Interventions to Improve Glycaemic Control in Type 1 Diabetes. DIABETES, Vol. 66 (pp A214-A214)
• Thokala P, Brennan A, Lafortune L & Brayne C (2016) . Value in Health, Vol. 19(7) (pp A853-A853)
• Porter JK, Brennan A, Palmer S, Sapra S & Cristino J (2016) . Value in Health, Vol. 19(7) (pp A361-A361)
• de Vocht F, Heron J, Mooney J, Angus C, Lock K, Egan M, Campbell R, Brennan A & Hickman M (2016) . Posters (pp A83.1-A83)
• de Vocht F, Heron J, Mooney J, Brennan A, Lock K, Campbell R & Hickman M (2015) . The Lancet, Vol. 386 (pp S33-S33)
• Graham J, McBride D, Stull D, Halliday A, Alexopoulos ST, Balp M, Griffiths M, Agirrezabal I & Brennan A (2015) . Value in Health, Vol. 18(7) (pp A423-A423)
• Strong M, Brennan A & Oakley J (2015) . Value Health, Vol. 18(7) (pp A725-A726). Milan, Italy, 7 November 2015 - 7 November 2015.
• Meier PS, Holmes J, Meng Y & Brennan A (2014) . The Lancet, Vol. 384 (pp S51-S51)
• Holmes J, Meng Y, Meier PS, Brennan A, Angus C, Campbell-Burton A, Guo Y, Hill-McManus D & Purshouse RC (2013) Minimum unit pricing for alcohol: policy appraisal modelling of income and socioeconomic group-specific effects on consumption, spending, and health harms. LANCET, Vol. 382 (pp 47-47)
• Thokala P, Baalbaki H & Brennan A (2013) . VALUE IN HEALTH, Vol. 16(7) (pp A530-A530)
• Thokala P, Brennan A & Baalbaki H (2013) . Value Health, Vol. 16(3) (pp A290). United States
• Watson P & Brennan A (2013) . Value Health, Vol. 16(3) (pp A29). United States
• Sutherland CS, Gillet M, Brennan A, Duran A & Ansolabehere X (2013) . VALUE IN HEALTH, Vol. 16(3) (pp A284-A284)
• Kruger J, Brennan A, Thokala P, Basarir H, Jacques R & Elliott J (2013) The cost-effectiveness of five week vs one week DAFNE structured education in Type 1 diabetes: a preliminary evaluation using the Sheffield Type 1 diabetes policy model. DIABETIC MEDICINE, Vol. 30 (pp 131-131)
• Brennan A, Thokala P, Baalbaki H, Stevens JW, Wang J & Pandor A (2012) . VALUE IN HEALTH, Vol. 15(7) (pp A360-A360)
• Thokala P, Kruger J & Brennan A (2012) . VALUE IN HEALTH, Vol. 15(4) (pp A181-A182)
• Watson P & Brennan A (2012) Validation of an individual patient level simulation of the natural history of systemic Lupus erythematosus against an alternative longitudinal cohort. 2012 Operational Research Society Simulation Workshop Sw 2012 (pp 19-24)
• Tappenden P, Brennan A, Chilcott J & Squires H (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A469-A470)
• Tappenden P, Brennan A, Chilcott J & Squires H (2011) . VALUE IN HEALTH, Vol. 14(7) (pp A243-A243)
• Watson P, Brennan A, Birch H, Fang H & Petri M (2011) The Natural History and Predictive Factors of Long Term Outcomes in Systemic Lupus Erythematosus.. ARTHRITIS AND RHEUMATISM, Vol. 63(10) (pp S951-S951)
• Meier P, Brennan A & Purshouse R (2010) MODELLING GENERAL AND TARGETED PRICE POLICY OPTIONS: ESTIMATION OF EFFECTS ON DIFFERENT SUBGROUPS OF THE POPULATION. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Vol. 34(6) (pp 251A-251A)
• Brennan A & Gillett M (2010) MODELLING COST EFFECTIVENESS OF BEHAVIOUR MODIFICATION PROGRAMMES AND EFFECTS ON MEDICATION: CASE STUDY OF EDUCATION PROGRAMMES IN DIABETES. VALUE HEALTH, Vol. 13(3) (pp A59-A59)
• Gillett M, Dallosso HM, Dixon S, Brennan A, Carey ME, Campbell MJ, Heller S, Khunti K & Davies MJ (2009) Cost effectiveness of the DESMOND structured education programme for patients newly diagnosed with type 2 diabetes. DIABETOLOGIA, Vol. 52 (pp S12-S12)
• Brennan A, Gillett M & Duenas A (2008) ESTIMATING THE COST EFFECTIVENESS IN THE UK OF VILDAGLIPTIN COMPARED TO PIOGLITAZONE AS ADD-ON THERAPY TO METFORMIN USING THE SHEFFIELD TYPE 2 DIABETES MODEL. VALUE HEALTH, Vol. 11(6) (pp A501-A501)
• Stevenson MD, Rawdin AC, Karnon JD & Brennan A (2008) Clopidogrel is cost-effective compared with aspirin in United Kingdom patients with a myocardial infarction who subsequently sustain an ischaemic stroke or peripheral arterial disease event. VALUE HEALTH, Vol. 11(3) (pp A194-A195)
• Brennan A, Nagy B, Brandtmuller A, Thomas SK, Sullivan SD & Akehurst R (2007) The cost-utility of exelon patch in the management of patients with moderate Alzheimer's disease in the United Kingdom. VALUE HEALTH, Vol. 10(6) (pp A384-A384)
• Nixon R, Bansback N & Brennan A (2007) Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis. VALUE HEALTH, Vol. 10(3) (pp A121-A121)
• Brennan A, Wilson R, Davis S, Brandtmuller A & Akehurst R (2007) Economic evaluation of the use of lanthanum carbonate from an Australian perspective. NEPHROLOGY DIALYSIS TRANSPLANTATION, Vol. 22 (pp 186-186)
• Ara RM, Reynolds AV, Conway P & Brennan A (2006) The cost effectiveness of etanercept in patients with severe as in the UK. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 273-274)
• Brennan A, Bansback NJ, Nixon R, Madan J & Symmons D (2006) The cost effectiveness of anti-TNF antagonists in rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Registry. ANNALS OF THE RHEUMATIC DISEASES, Vol. 65 (pp 179-179)
• Bansback N, Young A, Dixey J & Brennan A (2005) A simple prognostic index in early rheumatoid arthritis for predicting functional outcome at 5 years follow up. RHEUMATOLOGY, Vol. 44 (pp I97-I97)
• Brennan A, Akehurst R, Davis S & Sakai H (2004) Lanthanum carbonate for the treatment of hyperphosphataemia: Development of a cost effectiveness model. VALUE HEALTH, Vol. 7(6) (pp 805-805)
• Bansback NJ, Brennan A & Sengupta N (2004) The cost effectiveness of adalimumab (HUMIRA (R)) in patients with RA: A Finnish analysis. ANNALS OF THE RHEUMATIC DISEASES, Vol. 63 (pp 513-514)
• Bansback NJ, Young A, Sollymossy C, Dixey J & Brennan A (2004) A prognostic model for progressive disease in early rheumatoid arthritis. ANNALS OF THE RHEUMATIC DISEASES, Vol. 63 (pp 110-110)
• Bansback NJ, Brennan A, Sengupta N & Pang F (2004) The cost effectiveness of adalimumab (HUMIRA((R))) in UK patients with moderate to severe RA. ANNALS OF THE RHEUMATIC DISEASES, Vol. 63 (pp 512-513)
• Brennan A & Ara R (2004) Cost effectivness of obesity treatment with sibutramine in combination with diet and lifestyle advice in Germany. INTERNATIONAL JOURNAL OF OBESITY, Vol. 28 (pp S152-S152)
• Bansback N, Brennan A & Sengupta N (2004) Cost-effectiveness of adalimumab (Humira (TM)) in the treatment of US patients with rheumatoid arthritis (RA). VALUE HEALTH, Vol. 7(3) (pp 241-241)
• Bansback NJ, Brennan A, Sengupta N & Chang KY (2003) Cost effectiveness of adalimumab (HUMIRA (TM), Abbott) in the treatment of patients with moderate to severe rheumatoid arthritis (RA). ARTHRITIS AND RHEUMATISM, Vol. 48(9) (pp S215-S215)
• Bansback NJ, Brennan A, Ghatnekar O, Sengupta N, Chang KY & Hansen M (2003) The cost-effectiveness of adalimumab (HUMIRA (TM), Abbott) in patients with rheumatoid arthritis: A Swedish analysis.. ARTHRITIS AND RHEUMATISM, Vol. 48(9) (pp S611-S611)
• Bansback N, Brennan A, Young A, Solymossy C & Dixey J (2003) Identifing groups of RA patients who are fast Progressors from early clinical and radiological. ARTHRITIS AND RHEUMATISM, Vol. 48(9) (pp S110-S110)
• Brennan A, Ward S & Hummel S (2002) Costing the impact of the cancer service guidance. Journal of Clinical Excellence, Vol. 4(1 SUPPL.) (pp 209-210)
• Bansback N, Brennan A, Conway P & Reynolds AV (2002) A threshold cost-effectiveness comparison of infliximab and etanercept in adults with rheumatoid arthritis in the UK.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S582-S582)
• Brennan A, Bansback N, Martha K, Peacock M & Huttner K (2002) Methods to analyse the economic benefits of a pharmacogenetic (PGt) test to predict response to biologic therapy in RA, and to prioritise further research.. ARTHRITIS AND RHEUMATISM, Vol. 46(9) (pp S92-S92)
• Brennan A, Bansback N, Conway P & Reynolds AV (2001) Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis (RA) in the UK.. ARTHRITIS AND RHEUMATISM, Vol. 44(9) (pp S157-S157)
• Bansback N, Brennan A, Reynolds A, Conway P & Hammond T (2001) In rheumatoid arthritis (RA) utility calculations should be derived from EQ5D rather than SF-36 due to floor effects.. ARTHRITIS AND RHEUMATISM, Vol. 44(9) (pp S311-S311)
• (2000) . PharmacoEconomics, Vol. 17(5) (pp 443-444)
• Masuku SD, Mandrik O, Mdege N, Mishra G, Muwonge R, Meyer-Rath G, Lince-Deroche N & Brennan A () Breast Cancer Screening Using Clinical Breast Examination: A Cost-Effectiveness Analysis for South Africa. TBA, 18 July 2025 - 23 July 2025.
• Basirir H, Brennan A, Jacques R, Pollard D, Stevens K, Freeman J, Wales J & Price K () . Endocrine Abstracts
• Thokala P, Baalbaki H, Lowrie K, Dixon S & Brennan A () . International Journal of Integrated Care, Vol. 13(7)
• Kruger J, Brennan A, Thokala P, Cooke D & Heller S () Accounting for Psychological Determinants of Treatment Response in Health Economic Simulation Models of Behavioural Interventions: A Case Study in Type 1 Diabetes. ISPOR 17th Annual International Meeting. Washington DC, June 2012.
• Kruger J, Brennan A, Thokala P, Fitzgerald P & Heller S ()

Reports

• Forster M, Flight L, Corbacho B, Keding A, Ronaldson S, Tharmanathan P, Welch C, Brennan A & Chick S (2021) Report for the EcoNomics of Adaptive Clinical Trials (ENACT) project : Application of a Bayesian Value-Based Sequential Model of a Clinical Trial to the CACTUS and HERO Case Studies (with Guidance Material for Clinical Trials Units)
• Hill J, Breeze P, Chrysanthou G, Bell H & Brennan A (2019) Summary report of the Health and Labour Outcomes (HaLO) Tool
• Webster L, Angus C, Brennan A & Gillespie D (2018)
• Hill J, Sechel C, Mukuria C, Brennan A, Roberts J & Bryan M (2018) A feasibility study for building a health and work model. Report prepared for Public Health England
• Pryce RE, Buykx P, Gray L, Stone T, Drummond C & Brennan A (2017) Estimates of alcohol dependence in England based on APMS 2014, including estimates of children living in a household with an adult with alcohol dependence. Prevalence, trends, and amenability to treatment
• Pryce RE, Angus C, Holmes J, Meier P & Brennan A (2016) Model-based appraisal of the comparative impact of Minimum Unit Pricing and taxation policies in Scotland. An adaptation of the Sheffield Alcohol Policy Model version 3,
• Holmes J, Angus C, Buykx P, Ally A, Stone A, Meier P & Brennan A (2016) Mortality and morbidity risks from alcohol consumption in the UK: Analyses using the Sheffield Alcohol Policy Model (v.2.7) to inform the UK Chief Medical Officers’ review of the UK lower risk drinking guidelines
• Breeze PR, Thomas C, Squires H, Brennan A, Greaves C, Diggle P, Brunner E, Tabak A, Preston L & Chilcott J (2015) SPHR Diabetes Prevention Model: Detailed Description of Model Background, Methods, Assumptions and Parameters
• Holmes J, Lovatt MJ, Ally A, Brennan A & Meier P (2015) A new approach to measuring drinking cultures in Britain
• Hill-McManus D, Angus CR, Meng Y, Holmes J, Brennan A & Meier P (2014) Injury Alcohol-Attributable Fractions: Methodological Issues and Developments
• Koh SCL, Marchand R, Genovese A & Brennan A (2012) Fuel Poverty: Perspectives from the front line
• Webster L, Angus C, Holmes J, Brennan A & Gillespie D ()
• Webster L, Angus C, Brennan A & Gillespie D ()
• Brennan A, Buykx P, Pryce RE, Jones A, Hill-McManus D, Stone T, Ally A, Gillespie D, Meier P, Alston R , Cairns D et al () An evidence-based model for estimating requirements for specialist alcohol treatment capacity in England: The Specialist Treatment for Alcohol Model (STreAM) Version 1.0

Posters

• Tosh J & Brennan A (2011) Health Economic Modelling of the Service of Care in Sheffield for Patients with Long-Term Depression.
• Nagy B, Brennan A, Brandtmuller A, Thomas SK, Sullivan SD & Akehurst R (2008) Cost-Utility of the Rivastigmine Transdermal Patch in the Management of Patients with Moderate Alzheimer's Disease in the US.
• Sadler S, Angus C, Gell L, Gillespie D, Holmes J, Brennan A & Meier P Comparing socioeconomic gradients in alcohol-related harm between the four UK countries (PHE Applied Epidemiology Scientific Meeting 18-19 March 2015).
• Thokala P, Dodd P, Dixon S & Brennan A Using real world data to structure and populate Markov models - a case study of telemonitoring for heart failure.
• Brennan A, Thokala P, Baalbaki H, Stevens J, Wang J & Pandor A Telemonitoring after discharge with heart failure - costeffectiveness modelling of alternative service designs (2012).
• Basarir H, Kruger J, Brennan A, Thokala P, Jacques R, Dixon S, Elliott J, Heller S & Mansell P The Cost-Effectiveness of 5-week versus 1-week DAFNE Structured Education in Type 1 Diabetes: A Preliminary Evaluation Using the Sheffield Type 1 Diabetes Policy Model (Diabetes UK Professional Conference 13-15 March 2013).
• Kruger J, Brennan A, Thokala P, Basarir H & Heller S The Cost-Effectiveness of Dose Adjustment For Normal Eating (DAFNE) Structured Education in Type 1 Diabetes: An Update using the Sheffield Type 1 Diabetes Policy Model (Diabetes UK Professional Conference 13-15 March 2013).
• Brennan A & Gillett M Modelling cost effectiveness of behaviour modification programmes and effects on medication: case study of education programmes in diabetes.
• Tappenden P, Brennan A, Chilcott J & Squires H Using Whole Disease Modelling to inform economic recommendations for the detection, diagnosis, treatment and followup of colorectal cancer.

Datasets

• Gillespie D, Hatchard J, Squires H, Gilmore A & Brennan A .

Other

• Gillespie D, Webster L & Brennan A () .
• Gillespie D, Webster L, Angus C & Brennan A () .

Preprints

• Kalbus A, Adams J, Brown KA, Breeze P, Brennan A, Cummins S, Marks D, Law C, O’Neill S, Smith R , Tanasache O-A et al (2025) , Cold Spring Harbor Laboratory.
• Breeze P, Lake A, Moore H, Connor N, Burrows A, Pidd K, Reynolds C, Wells R, Vogel C & Brennan A (2024) , Springer Science and Business Media LLC.
• Breeze P, Pidd K, Pollard D, Ren S, Bates S, Thomas C, Ahern A, Griffin S & Brennan A (2024) , Springer Science and Business Media LLC.
• Angus C, Holmes J, Purshouse R, Meier P & Brennan A (2022) , Cold Spring Harbor Laboratory.
• Flight L, Brennan A, Chick SE, Forster M, Julious S & Tharmanathan P (2022) Value-adaptive clinical trial designs for efficient delivery of research – actions, opportunities and challenges for publicly funded trials.
• Richards R, Jones RA, Whittle F, Hughes CA, Hill AJ, Lawlor ER, Bostock J, Bates S, Breeze PR, Brennan A , Thomas CV et al (2021) , JMIR Publications Inc..
• Kunst NR, Wilson E, Alarid-Escudero F, Baio G, Brennan A, Fairley M, Glynn D, Goldhaber-Fiebert JD, Jackson C, Jalal H , Menzies NA et al (2019) , arXiv.
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S & Ismail K () .
• Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S & Ismail K () .